Emerging Computational Advances in Simulating PCSK9 Variant Dynamics for Therapeutic Design Against Hypercholesterolemia
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a premier model for precision medicine, having moved from genetic discovery to approved therapeutics within two decades. Yet despite the clinical success of monoclonal antibodies, small interfering RNA and the newly approved oral macrocyclic-peptide inhibitor cla...